Navigation Links
New insights into the fate of anti-parasitics in manure and manured soils

In recent years, there has been growing interest in the question, if the entry of veterinary medicinal products (VMP) into soils via manure application is of environmental relevance. In a recent study, published in the November issue of the journal CLEAN, Kreuzig and co-workers now focused on the so far less investigated benzimidazole antiparasitics, adding valuable data to the so far available data set on fate and behavior of veterinary medicinal products in manure and manured soils.

An innovative experimental design for laboratory tests on VMP has been developed in order to simulate the real entry route of VMP into soil environments already under laboratory conditions. Degradation tests of VMP as 14C-labeled radiotracers in manures were conducted. On this basis, test manures containing 7-day aged VMP residues were prepared and then applied in laboratory batch tests to study degradation and sorption of VMP in manured soils. In further tests, the differentiation of microbial, chemical and photoinduced degradation were taken into account. Finally, test-plot experiments were performed under field conditions to monitor the transferability of the laboratory data to field conditions.

The benzimidazole antiparasitics flubendazole and fenbendazole mainly remained extractable in pig manure and soil samples. Antibiotics like sulfonamides, in contrast, rapidly formed non-extractable residues. Flubendazole was found unchanged while fenbendazole was accompanied by corresponding metabolites. Due to their slow degradation in pig manure, the manure storage is not considered to reduce substantially the environmental exposure. As shown by the sorption tests, both benzimidazoles did not fulfill the criteria of potential leachers. Finally, the degradation tests showed the dependence of the metabolic fate on the microbial activity in soil and on the test-manure application. These aspects, therefore, emphasized that the consideration of manure effects already under laboratory conditions supports a better understanding of the environmental fate of VMP under field conditions.


Contact: Vera Koester

Related biology technology :

1. Dental Implant Market Insights Webinar
2. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
3. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology:
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):